Right now there's growing anticipation among HCPs for @NovartisCancer NATALEE trial 6-year breast cancer survival results due to be presented at #ESMO26, according to @CREATION Intelligence. We're tracking the HCP reactions as they happen at ESMO, and if you're in pharma or an HCP, you can too! Get access at https://t.co/eyeMsE98vT